Bristol Myers Squibb nnounced that the U.S. Food and Drug Administration (FDA) has approved commercial production at the company’s newest cell therapy manufacturing facility in Devens, Massachusetts. The Devens site is a critical component of BMS’ expanding global cell therapy manufacturing footprint for long-term su…
Proteintech announces its Manchester office has moved and expanded. The new site is based at Transmission, a brand-new building in Enterprise City, the fastest-growing industrial district of the city center. The new space has doubled the footprint of the Manchester site to accommodate the expansion of operations, sale…
Novo Nordisk announced plans to invest 15.9 billion Danish kroner starting in 2023 to expand an existing Active Pharmaceutical Ingredient (API) production facility in Denmark for the future portfolio within serious chronic diseases. The investment comes as Novo Nordisk marks the 100th anniversary of its founding in D…
Telix Pharmaceuticals Limited welcomes Willy Borsus, Vice-President of Wallonia, Minister of Economy, Research and Innovation, Digital, Agriculture, Urban Planning and Regional Planning to officially open Telix Manufacturing Solutions, the Company's radiopharmaceutical production facility located in Brussels South (Se…
Ecolab Inc., the world’s water, hygiene and infection prevention company, announced a further expansion of its Purolite business with the addition of a new biologics resin manufacturing facility in Landenberg, Pennsylvania. Construction plans for the new facility are underway and will strengthen the security of supply…
Element Biosciences, Inc., the developer of the Element AVITI™ System, an innovative DNA sequencing platform disrupting genomics, is pleased to announce that the AVITI is now available in Europe, in addition to Asia and the Middle East. VIB, Flanders' leading life science research institute in Belgium; Lexogen, a glob…
Scivita Medical's headquarters, R&D and manufacturing plant was officially opened in Suzhou Industrial Park (SIP). This momentous occasion marks a significant milestone for Scivita Medical as it consolidates its key operations, encompassing R&D, production, marketing, doctor training, product display, and expe…
PharmaEssentia Corporation a global biopharmaceutical innovator headquartered in Taiwan leveraging deep expertise and proven scientific principles to deliver new biologics in hematology and oncology, announced plans for a new PharmaEssentia Innovation Research Center (PIRC) in the greater Boston, Massachusetts area. T…
NS Pharma announced the opening of a new office in Cambridge, Massachusetts, to establish the NS Pharma Innovation Research Partnering division. The new Boston area location is the company’s center for research and development (R&D) in the United States and will diversify Nippon Shinyaku’s R&D portfolio throu…
Being committed to continued advances in improving human health, SCHOTT has opened a new facility in Phoenix, Arizona, to expand the development and manufacturing of diagnostics and life science consumables. Launching the first fully integrated microfluidic foundry in the United States validates SCHOTT’s global growth…
Page 51 of 58